Strategic Partnerships Opportunity to expand presence in the US via Hyprevention INC in New York by aligning with US hospitals and orthopedics distributors focused on osteoporotic and cancer-related bone reinforcement devices.

Orthopedic Focus Target orthopedic surgeons and trauma centers treating vertebral compression fractures and hip fragility risk to introduce V-STRUT and Y-STRUT as vertebral and contralateral hip protection options.

Aging Population Capitalize on growing demand from aging populations with osteoporosis, emphasizing reduced vertebral fracture risk and maintained autonomy to drive adoption in hospital procurement and clinical workflows.

Clinical Education Leverage collaboration with Dawa Medical and ongoing conferences to position Hyprevention as a knowledge partner, creating co-branded education and case studies that facilitate trial and adoption.

Clinical Economics Highlight cost-saving and quality-of-life benefits of STRUTPLASTY technology to payers and hospital administrators, supporting ROI narratives for shorter hospital stays and reduced re-fracture rates.